What is Pulmonx?
Pulmonx is a respiratory medical device company company serving enterprise, commercial, consumer, healthcare, financial, real estate, or regulated-market customers.
- Category
- Respiratory medical device company
- Headquarters
- Redwood City, United States
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: LUNG
What is Pulmonx?
Pulmonx is a respiratory medical device company company headquartered in Redwood City, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
Pulmonx is a respiratory medical device company company headquartered in Redwood City, United States. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, Pulmonx should be mapped as a scaled public-company account. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does Pulmonx offer?
Pulmonx's profile centers on COPD treatment, Endobronchial valves, Pulmonology devices, Clinical support.
- COPD treatment· Respiratory medical device company
- Endobronchial valves· Respiratory medical device company
- Pulmonology devices· Respiratory medical device company
- Clinical support· Respiratory medical device company
- Medical technology· Respiratory medical device company
- Patient selection· Respiratory medical device company
How does Pulmonx make money?
Pulmonx makes money through commercial activity tied to respiratory medical device company.
Pulmonx monetizes through the model common to respiratory medical device company: product sales, recurring services, contracts, leases, subscriptions, transaction volume, servicing, investment management, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, occupancy, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads Pulmonx?
Pulmonx's named executives should be verified on the official leadership or investor-relations page before outreach.
- Pulmonx executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- Pulmonx finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- Pulmonx operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact Pulmonx's leadership?
Pulmonx should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://pulmonx.comHow is Pulmonx funded?
Pulmonx's current status is Public company; Nasdaq: LUNG.
Pulmonx's capital profile is best understood through its current public-company status: Public company; Nasdaq: LUNG. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did Pulmonx get here?
Pulmonx's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingPulmonx is foundedThe company begins building in respiratory medical device company.
- Scale-upCommercial footprint expandsPulmonx broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: LUNGPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are Pulmonx's competitors?
Pulmonx competes with larger incumbents and focused specialists in respiratory medical device company.
Pulmonx — frequently asked questions
